ArticleJournal of virology2025
ATG5 negatively regulates grass carp reovirus-induced immune-inflammatory response by degrading RIG-I and MDA5.
Article in Journal of virology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Grass carp reovirus (GCRV) is the most virulent aquareovirus, inducing hemorrhagic disease that results in significant economic losses for the grass carp aquaculture industry in China. It has been reported that the cytokine storm, resulting from the viral-induced acute immune-inflammatory response, is the primary cause of death associated with viral infections. Therefore, exploring the negative regulatory factors of the immune response may provide important targets for virus prevention and control. In this study, we demonstrated that GCRV infection induces an acute immune-inflammatory response in yearling grass carp, while a milder immune response is observed in 3-year-old grass carp by assessing key gene expression at both the mRNA and protein levels. Furthermore, we found that the upregulation of autophagy core gene, autophagy-related gene 5 (ATG5), inhibits GCRV replication and reduces the excessive immune-inflammatory response induced by the virus. Notably, co-immunoprecipitation and bimolecular fluorescence complementation reveal that ATG5 interacts with RIG-I and MDA5, inhibiting the downstream immune response. Mechanistically, ATG5 promotes autophagy and K48-linked polyubiquitination to degrade RIG-I and MDA5. Importantly, ATG5 reduces IRF7 phosphorylation through the degradation of RIG-I and MDA5, which, in turn, leads to a decreased immune response during GCRV infection. Collectively, our findings suggest that ATG5 serves as an important negative regulatory factor of the viral-induced acute immune-inflammatory response, providing a promising target for the prevention and control of GCRV. IMPORTANCE: Grass carp reovirus (GCRV) is a highly virulent pathogen responsible for hemorrhagic disease in grass carp, leading to devastating losses in aquaculture. The study reveals that GCRV triggers an acute immune-inflammatory response in young grass carp, which is linked to high mortality, while a milder immune response occurs in older, resistant fish. Importantly, the autophagy-related gene ATG5 was identified as a critical regulator that suppresses excessive immune-inflammatory responses by promoting the degradation of RIG-I and MDA5, two key viral sensors. ATG5 not only reduces viral replication but also limits IRF7 phosphorylation, a key step in interferon signaling. This research uncovers a novel mechanism by which autophagy moderates viral-induced immune response, suggesting that ATG5 could be a valuable target for therapeutic interventions aimed at controlling GCRV infection and preventing cytokine storms in aquaculture. These findings could have broader implications for managing viral infections in fish farming.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.